This is an editorial summary of research originally reported by . ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
Free weekly digest
We track health and safety research on food, cosmetics, and household products and send you what matters. Join 27 readers.
What would you like to do next?
I use this product
Get the next safety alert before it goes viral
Free weekly digest of health findings about everyday products. No spam, unsubscribe any time.
Advertisement
Get the latest health findings delivered to your inbox. Only the important stuff. No spam.
We'll send a confirmation email. Unsubscribe anytime.
HIV treatment and prevention programs in parts of Zambia have weakened following cuts to U.S. assistance, threatening progress that had saved hundreds of thousands of lives. The collapse of these services puts people at risk of infection and makes it harder for those living with HIV to access the medications they need. This matters because it shows how quickly gains in fighting a deadly disease can disappear when funding drops.
A once-robust H.I.V. treatment and prevention system, credited with saving hundreds of thousands of lives, has begun to crumble.
This summary is based on reporting by NYT Health. For the complete article and full research details, see the original report linked below.
Always consult a healthcare professional for personal medical advice.
Read the full report at the original source
NYT HealthWas this finding useful?
Community discussion
Join the discussion
Comments are reviewed before appearing publicly.